1. Pink Sheet
  2. >>Compliance
  3. >>Distribution/Supply Chain

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

 
• By Sue Sutter

Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.

Supply chain
Drug shortages, foreign manufacturing and supply chain vulnerability were a common, intertwined thread throughout the appropriations subcommittee hearing. • Source: Shutterstock

In between many tobacco and vaping questions, US Food and Drug Administration Commissioner Robert Califf still managed to tout priorities important to drug oversight during a House subcommittee hearing on the agency's fiscal year 2025 budget request.

The Biden Administration has requested $7.2bn for the FDA in FY 2025, including $3.5bn in user fees and $3.7bn in discretionary budget authority

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Distribution/Supply Chain

More from Compliance

US FDA’s Expanded Surprise Foreign Inspections: Impact And Enforcement Hoops

 
• By Anju Ghangurde

As the US FDA expands unannounced foreign inspections building on pilots in India and China, experts expect higher scrutiny of overseas sites and perhaps even an industry shakeout in the longer term, though staffing and enforcement challenges could slow things down.

Pharma Industry Argues Tax, Other Incentives Better Than Tariffs

 
• By Jessica Merrill

Pharmaceutical industry organizations offered alternatives to tariffs that could maintain a secure domestic supply chain in public comments filed in response to a federal 232 investigation.

US FDA Expands Surprise Foreign Inspections But Loses Associate Commissioner Michael Rogers

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.